In part 4 of this Exclusive Interview, Dr. Mary Loeken talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, CA about reducing the risk of birth defects in women with diabetes.
Read More »Steve Freed, R.PH., CDE
Mary Loeken Part 5, Researching Diabetes Medication For Birth Defects
In part 5 of this Exclusive Interview, Dr. Mary Loeken talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, CA about finding ways to study the effects of diabetes drugs on pregnant women.
Read More »Mary Loeken Part 6, Results From Research of Diabetes Birth Defects
In part 6 of this Exclusive Interview, Dr. Mary Loeken talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, CA about the research to reduce the risk of birth defects and other potential risks of diabetes.
Read More »Mary Loeken Part 7, Improvements In The Prevention of Diabetes Birth Defects
In part 7 of this Exclusive Interview, Dr. Mary Loeken talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, CA about the advances in research to decrease the risk of birth defects in pregnant women with diabetes.
Read More »Mary Loeken Part 8, What Would You Like To Accomplish
In part 8, the conclusion of this Exclusive Interview, Dr. Mary Loeken talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, CA about her dreams for future accomplishments in her research. Mary Loeken, PhD is an Associate Professor of Medicine at Harvard Medical School …
Read More »Ray Kausik Part 2, PCSK9 Effect On HDL Goal Levels
In part 2 of this Exclusive Interview, Dr. Ray Kausik talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 convention in San Diego, CA about the impact of PCSK9 inhibitor on cholesterol.
Read More »A Better Way to Diagnose and Treat Patients Than Doctors?
With millions of possible drug combinations for treatment of diabetes, hypertension, hyperlipidemia and heart disease, new AI program offers more thorough analysis and options.
Read More »SGLT-2 Inhibitors Vs DPP-4 Inhibitors Vs. GLP1’s For Type 2 Diabetes
How best to decide whether to use one or a combination of the new treatments and individualize the treatment for your patients.
Read More »Emily Seto Current Interview
Emily Seto is an Assistant Professor and Lead for the health informatics programs at the Institute of Health Policy, Management and Evaluation at the University of Toronto.
Read More »Emily Seto Transcript
In this interview transcript, Emily Seto discusses the emerging field of mHealth (mobile health) which looks at how mobile technologies such as health apps and wearables can be used in healthcare.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.